Diagnosing osteoporosis at the point-of-care (Courtesy of Bone Index)
Imagine diagnosing osteoporosis at the point-of-care—without radiation. That’s what Finnish company Bone Index is proposing with its Bindex ultrasound device. It evaluates the cortical bone thickness of the tibia and immediately calculates the density index, which has historically been obtained using large dual-energy X-ray absorptiometry (DXA) machines in hospitals. Plugged directly into a laptop loaded with special software, Bindex can perform exams at the point-of-care.
The device received U.S. Food and Drug Administration (FDA) clearance in May. The manufacturer claims that research and practical trials have demonstrated results comparable to DXA readings. According to Bone Index, it gives reliable results in just 30 seconds, allowing physicians to perform more screenings, and to order treatment or medication immediately. Bindex is also very easy to use in any environment thanks to the “plug and examine” system.
Worldwide, an estimated 200 million people are afflicted with osteoporosis. Bone Index suggests its device could help the 75% who have not been diagnosed.